Investment
Features
FeesSafety
Academy
More
Pluang+

Compare Quest Diagnostics Inc (DGX) vs Kroger Co (KR) Price & Performance

Quest Diagnostics IncTrade

Price performance (Past 24H)

Key statistics

Quest Diagnostics Inc vs Kroger Co — how do they compare? Quest Diagnostics Inc trades at $230.72 (market cap $25.06B), while Kroger Co trades at $61.26 (market cap $34.99B). The key difference: Kroger Co is the larger of the two by market cap, and Kroger Co pays the higher dividend (2.63%). Which is the better fit depends on your goals — on Pluang, investors hold Quest Diagnostics Inc for 56 Days and Kroger Co for 108 Days on average.

DGXKR
Market Cap
$25.06B$34.99B
Volume
927,3618,938,607
Sector
HealthConsumer Staples
52-Week High
$247.45$75.60
52-Week Low
$173.49$55.53
Typical Hold Time
56 Days108 Days
Enterprise Value
$30.82B$56.41B
Dividend Yield
1.52%2.63%

Aura AI Summary

Signals from Pluang's Aura AI — not financial advice

Quest Diagnostics Inc

Quest Diagnostics (DGX) trades at $230.81, up 1.03% with consistent earnings beats in recent quarters. The stock shows bearish technical signals despite strong fundamentals including 9.19% net margins and 14.35% ROE. Recent developments include a partnership with Apple Health app and concerns about Medicare reimbursement cuts affecting future revenue streams.

The outlook remains cautiously optimistic with a $250 consensus price target representing 8.3% upside potential. Key opportunities include growth in advanced diagnostics and consumer testing demand, while risks center on Medicare payment reductions and competitive pressures in the diagnostic services market.

Kroger Co

Kroger (KR) trades at $61.41, up 5.14% today, with a bullish technical signal from moving averages. The stock shows strong fundamentals with $147.12B in revenue, though net margins remain thin at 0.73%. Recent earnings show mixed results with Q2 2026 beating expectations but Q1 2026 missing. The company maintains positive cash flow generation and continues dividend payments while facing competitive pressures in the grocery sector.

Kroger presents a balanced investment case with attractive valuation metrics (P/S 0.25) and analyst consensus pointing to 15% upside to $70.62 target. However, risks include integration challenges from acquisitions, margin pressure from price competition, and softer 2026 sales guidance. The stock offers value characteristics with dividend yield support amid ongoing digital transformation efforts.

Returns comparison

Trailing returns across standard periods

Investor sentiment on Pluang

What Pluang investors did over the last 30 days

DGX

No sentiment data available yet.

KR
76% Buy24% Sell
Avg holding period · 108 Days

Top news

Latest headlines on both assets

About Quest Diagnostics Inc

Quest Diagnostics is a leading independent provider of diagnostic testing, information, and services in the U.S. The company generates over 95% of its revenue through clinical testing, anatomic pathology, esoteric testing, and substance abuse testing with specimens collected at its national network of roughly 2,300 patient service centers, as well as multiple doctors offices and hospitals. The firm also runs a much smaller diagnostic solutions segment that provides clinical trials testing, risk assessment services, and information technology solutions.

Read more on DGX →

About Kroger Co

Kroger is the leading American grocer, with 2,726 supermarkets operating under several banners throughout the country as of the end of fiscal 2021. Around 83% of stores have pharmacies, while nearly 60% also sell fuel. The company also operates roughly 120 fine jewelry stores. Kroger features a leading private-label offering and manufactures around 30% of its own-brand units (and more than 40% of its grocery own-label assortment) itself, in 33 food production plants nationwide. Kroger is a top-two grocer in most of its major markets (as of early 2021, according to company data). Virtually all of Kroger's sales come from the United States.

Read more on KR →